Delivery Order SPE2DB20D1004-SPE2DB22FF5V7
- Not listed
- The federal contract award SPE2DB20D7066|SPE2DB25FC1TV was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,016.99 Firm Fixed Price Delivery Order contract covers the supply of ESOMEPRAZOLE MAG DR 40 MG CAP 30S, a pharmaceutical product, with a completion date of December 4, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,925.62 firm fixed-price delivery order is for the supply of 4558923068 - ESOMEPRAZOLE MAG DR 20 MG CAP 90S, with an ultimate completion date of October 31, 2022. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,834.45 firm fixed price delivery order is for the supply of 4563249507 - ESOMEPRAZOLE MAG DR 40 MG CAP 1000S, with a period of performance through January 8, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, with an ID of SPE2DB20D2104|SPE2DB23FQ76Z, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,826.69 Delivery Order is for the supply of 4558809522 - ESOMEPRAZOLE MAG DR 20 MG CAP 90S, with an ultimate completion date of October 19, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award, SPE2DB20D3104|SPE2DB22FV3T8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,010.06 firm fixed-price delivery order is for the supply of 4555509454 - ESOMEPRAZOLE MAG DR 40 MG CAP 30S, with a period of performance ending on November 24, 2021. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of...
- This federal contract award, with ID SPE2DB22D1017|SPE2DB24FG3EM, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,417.64 firm-fixed-price delivery order is for the supply of 4565454388 - ESOMEPRAZOLE MAG DR 40 MG CAP 30S, a prescription medication. This award is not associated with any set-aside program. The contract has an ultimate completion date of August 15, 2024. AmerisourceBergen holds a significant Indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, identified as SPE2DX15D7067|SPE2DX24F2ZLC, is for the supply of ESOMEPRAZOLE MAG DR 20 MG CAP 90S, a generic medication. The contract has a ceiling value of $27,793.11 and a completion date of June 12, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a...
- This is a federal delivery order award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $2,288.75, is for the supply of ESOMEPRAZOLE MAG DR 40 MG CAP 90S, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026....
- This federal contract award, valued at $4,319.99, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award, valued at $2,378.21, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB22FF5V7Delivery Order
This federal contract award, SPE2DB20D1004|SPE2DB22FF5V7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The $1,360.78 firm-fixed-price delivery order is for the supply of 4557045057 - ESOMEPRAZOLE MAG DR 20 MG CAP 30S. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies in support of military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 4/28/22 |